ZzzQuil Night Pain Berry Recalled Due to Improper Storage
ZzzQuil Night Pain Berry 12 FL OZ distributed to Family Dollar Stores from April 30 through June 10, 2022, was held outside appropriate storage temperature conditions, which may compromise medication stability and integrity.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. Improper storage temperature of a drug represents a material risk-of-harm to medication stability and effectiveness, warranting a High severity score.
Plain-English summary
ZzzQuil Night Pain Berry 12 FL OZ is an over-the-counter sleep aid and pain reliever product distributed to Family Dollar Stores. The FDA recalled the product due to Current Good Manufacturing Practice (CGMP) deviations.
Specifically, the affected product was held outside appropriate storage temperature conditions during the distribution period of April 30, 2022 through June 10, 2022. Improper storage temperatures may affect the stability and therapeutic efficacy of the medication.
The product (SKU 903452) was distributed nationwide to specific Family Dollar Store locations. The recalling firm is Family Dollar Stores, LLC.
The recalled product
- Product
- ZZZQUIL NIGHT PAIN BERRY 12 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Sleep Aid
- Hazard
- improper-storage
- temperature-excursion
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 903452
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27